You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NGNE Exercise Disclosure
Mcminn Rachel · SEC Form 4 · Filed Oct 2, 2026
Exercise
Calculated transaction value
$19.14K
Mcminn Rachel Chief Executive Officer
NGNE
Neurogene
NGNE
Transaction date
Sep 22, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 10 days later
NGNE daily price context
Close on/before transaction
$33.6
Sep 22, 2026
First close after public filing
$25.65
Oct 2, 2026
30-day return after filing
+3.74%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 756 shares @ $25.32
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001606302-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$19.14K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurogene Inc. NGNE Current | Exercise | Sep 22, 2026 | $19.14K |
| Neurogene Inc. NGNE | Exercise | Sep 22, 2026 | $0 |